Does Myasthenia Gravis Affect Long-Term Survival in Thymic Carcinomas? An ESTS Database Analysis.
Fiche publication
Date publication
juillet 2022
Journal
Diagnostics (Basel, Switzerland)
Auteurs
Membres identifiés du Cancéropôle Est :
Pr FALCOZ Pierre-Emmanuel
Tous les auteurs :
Lococo F, Nachira D, Chiappetta M, Evangelista J, Falcoz PE, Ruffini E, Van Schil P, Scarci M, Furàk J, Sollitto F, Guerrera F, Spaggiari L, Aigner C, Evangelia L, Billè A, Moser B, Thomas PA, Liberman M, Boubia S, Campisi A, Ampollini L, Toker A, Enyed A, Voltolini L, Van Raemdonck D, Margaritora S, Ests Thymic Working Group
Lien Pubmed
Résumé
Thymic carcinoma is a rare and highly malignant tumor with a dismal prognosis, which occasionally coexists with myasthenia gravis (MG). This study aims to investigate the MG incidence on a surgical cohort of patients with thymic carcinoma and to explore its influence on long-term survival.
Mots clés
myasthenia gravis, recurrence, surgery, thymic carcinoma
Référence
Diagnostics (Basel). 2022 07 21;12(7):